ADC Therapeutics (ADCT) Cash & Equivalents (2019 - 2026)
ADC Therapeutics (ADCT) posted Cash & Equivalents of $219.11 million for Q2 2026, down 17.2% from $264.56 million a year earlier and down 5.2% from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, ADC Therapeutics' Cash & Equivalents came in at $261.34 million, up 4.2% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -9.9% (FY2020 to FY2025).
- In prior years, ADC Therapeutics' Cash & Equivalents was $250.87 million in FY2024 (-10.0%), $278.6 million in FY2023 (-14.7%), $326.44 million in FY2022 (-30.0%) and $466.54 million in FY2021 (+6.2%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q1 2025.
- On a year-over-year basis, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 7.4%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2026, with growth of 18.6%; the weakest was Q4 2022, with a decline of 30.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $231.01 million (Q1 2026), $261.34 million (Q4 2025) and $234.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | ADC Therapeutics | 202.63 Mn | -743.56 Mn | 16.90 Mn | 219.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 219.11 Mn |
| Mar 31, 2026 | 231.01 Mn |
| Dec 31, 2025 | 261.34 Mn |
| Sep 30, 2025 | 234.74 Mn |
| Jun 30, 2025 | 264.56 Mn |
| Mar 31, 2025 | 194.70 Mn |
| Dec 31, 2024 | 250.87 Mn |
| Sep 30, 2024 | 274.30 Mn |
| Jun 30, 2024 | 300.12 Mn |
| Mar 31, 2024 | 234.30 Mn |
| Dec 31, 2023 | 278.60 Mn |
| Sep 30, 2023 | 310.41 Mn |
| Jun 30, 2023 | 347.51 Mn |
| Mar 31, 2023 | 310.55 Mn |
| Dec 31, 2022 | 326.44 Mn |
| Sep 30, 2022 | 380.86 Mn |
| Jun 30, 2022 | 376.78 Mn |
| Mar 31, 2022 | 430.87 Mn |
| Dec 31, 2021 | 466.54 Mn |
| Sep 30, 2021 | 530.19 Mn |
API Access
ADC Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();